(7429.31052017.113000204) COMM-NM_2790 (Q2318649): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Changed label, description and/or aliases in 2 languages: Changing unique label-description pair) |
||
description / en | description / en | ||
Project in Italy | Project Q2318649 in Italy | ||
description / it | description / it | ||
Progetto in Italia | Progetto Q2318649 in Italia |
Revision as of 16:24, 4 November 2020
Project Q2318649 in Italy
Language | Label | Description | Also known as |
---|---|---|---|
English | (7429.31052017.113000204) COMM-NM_2790 |
Project Q2318649 in Italy |
Statements
42,640.24 Euro
0 references
170,560.96 Euro
0 references
25.0 percent
0 references
25 September 2017
0 references
25 March 2019
0 references
13 September 2019
0 references
CNR - CONSIGLIO NAZIONALE DELLE RICERCHE - ISTITUTO DI SCIENZA E TECNOLOGIE DELL'INFORMAZIONE "A.FAEDO" - PISA
0 references
L?IDEA ALLA BASE DEL PROGETTO ? QUELLA DI SPERIMENTARE UNA NUOVA TECNOLOGIA NELL?AMBITO DELL?IMAGING MOLECOLARE (IM), CHE CI POSSA PERMETTERE DI CREARE INNOVAZIONE SIA IN CAMPO SCIENTIFICO CHE INDUSTRIALE IMPLEMENTANDO I RISULTATI E LE RICADUTE SOCIOSANITARIE ED ECONOMICHE IN QUESTA BRANCA DELLA MEDICINA.L?OBIETTIVO ? QUELLO DI PROGETTARE E VALIDARE UNA PIATTAFORMA DIAGNOSTICA CHE INTEGRI IN UNA SOLA MACCHINA SENSORI DI MEDICINA NUCLEARE (PET - TOMOGRAFIA AD EMISSIONE DI POSITRONI OPPURE SPECT ? TOMOGRAFIA COMPUTERIZZATA CON EMISSIONE DI SINGOLI FOTONI) CON LA TECNOLOGIA CBCT (CONE BEAM COMPUTED TOMOGRAPHY) AL FINE DI CREARE UN IBRIDO CON ELEVATA PERFORMANCE DIAGNOSTICA MA CON ULTERIORI VANTAGGI COSTITUITI DALLA MANEGGEVOLEZZA E TRASPORTABILIT? DATE LE RIDOTTE DIMENSIONI NONCH? DALL?ESTREMA COMPATTEZZA E DUTTILIT?. TALE TECNOLOGIA DI IMAGING IBRIDO (PET/CBCT E SPECT/CBCT) SAR? NEI NOSTRI INTENTI DEDICATA IN PARTICOLAR MODO ALLO STUDIO DIAGNOSTICO DELLE PATOLOGIE NEURO-DEGENERATIVE E DE (Italian)
0 references
THE IDEA BEHIND THE PROJECT? TO TEST A NEW TECHNOLOGY IN MOLECULAR IMAGING (IM), WHICH WOULD ENABLE US TO CREATE BOTH SCIENTIFIC AND INDUSTRIAL INNOVATION BY IMPLEMENTING THE RESULTS AND THE SOCIAL AND HEALTH AND ECONOMIC IMPACTS IN THIS MEDICINA.L? OBJECTIVE? DESIGN AND VALIDATE A DIAGNOSTIC PLATFORM INTEGRATING INTO ONE MACHINE NUCLEAR MEDICINE SENSOR (PET — POSITRON EMISSION TOMOGRAPHY OR SPECT? COMPUTED TOMOGRAPHY WITH INDIVIDUAL PHOTON EMISSIONS) WITH THE CBT-TECHNOLOGY (CONE BEAM COMPUTED AND TOMOGRAPHY) TECHNOLOGY IN ORDER TO CREATE A HYBRID WITH A HIGH DIAGNOSTIC PERFORMANCE BUT WITH ADDITIONAL BENEFITS OF THE MANAGEABILITY AND TRANSITICISITILIT? GIVEN THE SMALL SIZE OF THE PRODUCT? FROM THE EXTREME COMPACT AND DURWEN?. THIS HYBRID IMAGING TECHNOLOGY (PET/CPC AND SPECTC/CBCT) SAR? OUR AIMS IN PARTICULAR FOR THE DIAGNOSTIC STUDY ON NEURO-DEGENERATIVE DISEASES AND DE (English)
0 references
Identifiers
D55F17001050009
0 references